THBD and endothelial dysfunction: Based on these and other findings [3,4,5], soluble thrombomodulin levels have been suggested as a marker of endothelial dysfunction and were found to be significantly elevated in patients with peripheral occlusive arterial or ischemic heart disease [6] or in patients with myocardial infarction suffering a pre-defined endpoint during follow-up [7].